Alembic Pharma Receives U.S. FDA Approval For Breast Cancer Injection

NDTV Profit

Published On

27 Dec 2022, 01:37 PM IST

Last Updated On

27 Dec 2022, 01:37 PM IST

#AlembicPharma receives U.S. #FDA's approval for Fulvestrant Injection, which is used in treatment of breast cancer.CFO Rajkumar Kumar Baheti shares what it means for the company. #BQLive

Add us to your Preferences

Set as your preferred source on Google

RECOMMENDED FOR YOU

Deals, Drugs, And Disruption: Glenmark, Lupin, IPCA Labs And Others Lead India's Pharma Opportunity Boom

GST Reforms To Inject Rs 2 Lakh Crore Into Economy, Says Finance Minister Nirmala Sitharaman

BioNTech Says Experimental Breast Cancer Drug Succeeded In Trial

New Clinical Trial Shows Repurposed Drugs Can Prevent Breast-Cancer Recurrence By Eliminating Hidden Cells